UNIVERSITY OF CALIFORNIA, DAVIS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1905-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucdavis.edu
Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Phase 1
Completed
- Conditions
- Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2010-03-29
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 42
- Registration Number
- NCT00387322
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 24
- Registration Number
- NCT00388089
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART
Not Applicable
Completed
- Conditions
- HyperlipidemiaHIV Infections
- Interventions
- Other: placeboDietary Supplement: L-carnitine
- First Posted Date
- 2006-10-12
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 13
- Registration Number
- NCT00386971
- Locations
- 🇺🇸
GCRC UC Davis, Sacramento, California, United States
Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements in Ghana
Phase 4
Completed
- Conditions
- Micronutrients
- First Posted Date
- 2006-09-21
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 393
- Registration Number
- NCT00379158
Cetuximab in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Biological: cetuximabGenetic: molecular diagnostic methodOther: immunologic techniqueOther: laboratory biomarker analysis
- First Posted Date
- 2006-09-15
- Last Posted Date
- 2010-03-29
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 27
- Registration Number
- NCT00376727
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
Molecular and Cellular Characterization of Spongiotic Dermatitis
Completed
- Conditions
- PsoriasisContact DermatitisAtopic Dermatitis
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 31
- Registration Number
- NCT00371163
- Locations
- 🇺🇸
UC Davis Department of Dermatology, Sacramento, California, United States
Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy
- First Posted Date
- 2006-08-25
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 12
- Registration Number
- NCT00368654
- Locations
- 🇺🇸
University of California, Davis Medical Center Department of Dermatology, Sacramento, California, United States
Beta Blocker for Chronic Wound Healing
- First Posted Date
- 2006-08-25
- Last Posted Date
- 2015-04-07
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 40
- Registration Number
- NCT00368602
- Locations
- 🇺🇸
VA Medical Center, Mather, California, United States
Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers
Phase 3
Terminated
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2006-08-25
- Last Posted Date
- 2015-04-07
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 20
- Registration Number
- NCT00368693
- Locations
- 🇺🇸
University of California, Davis Medical Center Department of Dermatology, Sacramento, California, United States
🇺🇸VA Medical Center, Mather, California, United States
Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis
- First Posted Date
- 2006-08-25
- Last Posted Date
- 2015-04-07
- Lead Sponsor
- University of California, Davis
- Registration Number
- NCT00368719
© Copyright 2025. All Rights Reserved by MedPath